Vivjoa (oteseconazole) is a prescription antifungal medication used to reduce the incidence of recurrent vulvovaginal candidiasis (RVVC) in females who have a history of RVVC and are not of reproductive potential. RVVC is a fungal infection of the vagina that occurs four or more times in a year.
Drug class: Azole antifungal
Indications:
- Recurrent vulvovaginal candidiasis (RVVC) in females who are not of reproductive potential
Mechanism of action:
Oteseconazole works by blocking the production of ergosterol, a substance that is essential for the growth and survival of Candida fungi. This leads to the death of Candida fungi and a relief of symptoms.
Dosage and administration:
Vivjoa is a capsule that is taken once daily for 180 days. It is important to take Vivjoa at the same time each day to maintain a consistent level of medication in your body.
Effectiveness:
In clinical studies, Vivjoa was shown to be effective in reducing the incidence of RVVC by up to 80% compared to placebo.
Side effects:
The most common side effects of Vivjoa are headache, nausea, and diarrhea. Other less common side effects include abdominal pain, vomiting, and dizziness.
Contraindications:
Vivjoa is contraindicated in women who are pregnant or breastfeeding, or for women with a history of certain liver diseases.
Conclusion:
Vivjoa is a safe and effective treatment for recurrent vulvovaginal candidiasis in females who are not of reproductive potential. It is important to talk to your doctor about the risks and benefits of Vivjoa before starting treatment.
Reviews
There are no reviews yet.